New psoriatic arthritis treatment guideline presented at the 2017 ACR/ARHP Annual Meeting

November 5, 2017, American College of Rheumatology

Authors of the new American College of Rheumatology (ACR) / National Psoriasis Foundation (NPF) treatment guideline for psoriatic arthritis (PsA) will present their draft recommendations during a session at the 2017 ACR/ARHP Annual Meeting this week in San Diego. The guideline includes pharmacologic and non-pharmacologic recommendations for treating adult patients with active psoriatic arthritis. Both the ACR and NPF anticipate the guideline will play an important role in improving outcomes for individuals living with PsA.

The guideline development team used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to develop the recommendations. GRADE uses systematic reviews of the scientific literature available to evaluate and grade the quality of evidence in a particular domain. The evidence reviews are then used to create for or against particular therapy options that range from strong to conditional, depending on the quality of evidence available.

Details of the draft recommendations will be presented on Tuesday, Nov. 7, from 1 - 2 p.m. PT.

The guideline manuscript is currently under peer review and is anticipated to be published in Arthritis & Rheumatology, Arthritis Care & Research and the Journal of Psoriasis and Psoriatic Arthritis in early 2018.

Explore further: New guideline aims to reduce infections in total hip and knee replacement patients

Related Stories

New guideline aims to reduce infections in total hip and knee replacement patients

June 20, 2017
According to a new guideline released by the American College of Rheumatology (ACR) and American Association of Hip and Knee Surgeons (AAHKS), the risk of joint infection resulting from total hip and knee replacements can ...

New guidelines published to improve diagnosis and treatment of lupus

October 9, 2017
A University of Birmingham academic has led the authorship of the UK's first guideline on the care of adults with systemic lupus erythematosus (lupus).

ACR Releases Guideline on prevention and treatment of glucocorticoid-induced osteoporosis

June 8, 2017
The American College of Rheumatology's (ACR) updated clinical guideline for the prevention and treatment of glucocorticoid-induced osteoporosis is now available online. The guideline provides recommendations on assessing ...

Patient, doctor panels develop similar RA recommendations

January 11, 2016
(HealthDay)—A voting panel composed of patients with rheumatoid arthritis develops recommendations that are very similar to those of a physician-dominated panel when there is evidence warranting moderate or high confidence, ...

Psoriatic arthritis patients need better screening, warns panel of experts

July 23, 2014
Leading experts have joined together for the first time to call for better screening of psoriatic arthritis to help millions of people worldwide suffering from the condition.

Recommended for you

New osteoarthritis genes discovered

March 19, 2018
In the largest study of its kind, nine novel genes for osteoarthritis have been discovered by scientists from the Wellcome Sanger Institute and their collaborators. Results of the study, published today (19 March) in Nature ...

Rheumatoid arthritis meets precision medicine

March 19, 2018
Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new Northwestern Medicine multi-site ...

Scientists use nanotechnology to detect molecular biomarker for osteoarthritis

March 12, 2018
For the first time, scientists at Wake Forest Baptist Medical Center have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology.

Biological engineers discover why a promising drug failed in clinical trials

March 7, 2018
Pharmaceutical companies once considered a protein called p38 a very attractive target for treating rheumatoid arthritis. Arthritis patients usually have elevated activity of this inflammation-producing protein, and in lab ...

Scorpion venom component can reduce severity of rheumatoid arthritis

February 26, 2018
A treatment that improves the lives of nearly 1.3 million people with rheumatoid arthritis might one day originate from scorpion venom. A group of researchers led by Dr. Christine Beeton at Baylor College of Medicine has ...

New device for low-cost single-cell analysis identifies fibroblast subtypes in rheumatoid arthritis patients

February 23, 2018
Single-cell analysis holds enormous potential to study how individual cells influence disease and respond to treatment, but the lack of cost-effective and user-friendly instrumentation remains challenging. As described in ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.